GAMUDA BHD
KLSE (MYR): GAMUDA (5398)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
7.85
Today's Change
0.00 (0.00%)
Day's Change
7.82 - 7.92
Trading Volume
6,391,900
Financial
Market Cap
21,786 Million
NOSH
2,775 Million
Latest Quarter
30-Apr-2024 [#3]
Announcement Date
25-Jun-2024
Next Quarter
31-Jul-2024
Est. Ann. Date
27-Sep-2024
Est. Ann. Due Date
29-Sep-2024
QoQ | YoY
12.93% | 5.56%
Revenue | NP to SH
12,042,352.000 | 891,388.000
RPS | P/RPS
433.91 Cent | 1.81
EPS | P/E | EY
32.12 Cent | 24.44 | 4.09%
DPS | DY | Payout %
15.78 Cent | 2.01% | 49.14%
NAPS | P/NAPS
4.17 | 1.88
QoQ | YoY
1.41% | -51.6%
NP Margin | ROE
7.59% | 7.70%
F.Y. | Ann. Date
30-Apr-2024 | 25-Jun-2024
Latest Audited Result
31-Jul-2023
Announcement Date
08-Nov-2023
Next Audited Result
31-Jul-2024
Est. Ann. Date
08-Nov-2024
Est. Ann. Due Date
27-Jan-2025
Revenue | NP to SH
8,233,552.000 | 1,838,401.000
RPS | P/RPS
296.67 Cent | 2.65
EPS | P/E | EY
66.24 Cent | 11.85 | 8.44%
DPS | DY | Payout %
47.96 Cent | 6.11% | 72.40%
NAPS | P/NAPS
3.89 | 2.02
YoY
128.03%
NP Margin | ROE
24.35% | 17.01%
F.Y. | Ann. Date
31-Jul-2023 | 27-Sep-2023
Revenue | NP to SH
11,500,708.000 | 852,853.333
RPS | P/RPS
414.39 Cent | 1.89
EPS | P/E | EY
30.73 Cent | 25.54 | 3.91%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
5.59% | -59.69%
NP Margin | ROE
7.66% | 7.37%
F.Y. | Ann. Date
30-Apr-2024 | 25-Jun-2024
Show?
| Last 10 FY Result | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,500,708 | 12,042,352 | 8,233,552 | 4,920,829 | 3,517,218 | 3,662,964 | 4,565,062 | 4,227,060 | 3,211,403 | 2,121,899 | 2,399,918 | 2,229,572 | 15.61% | |
| PBT | 997,646 | 1,091,532 | 1,067,575 | 885,800 | 786,250 | 585,462 | 908,849 | 729,302 | 826,002 | 780,658 | 858,189 | 851,645 | 2.54% | |
| Tax | -116,930 | -177,461 | 937,485 | -50,140 | -154,061 | -161,272 | -150,654 | -164,945 | -169,777 | -111,918 | -132,731 | -116,562 | - | |
| NP | 880,716 | 914,071 | 2,005,060 | 835,660 | 632,189 | 424,190 | 758,195 | 564,357 | 656,225 | 668,740 | 725,458 | 735,083 | 11.78% | |
| - | ||||||||||||||
| NP to SH | 852,853 | 891,388 | 1,838,401 | 806,225 | 588,316 | 371,680 | 706,113 | 513,883 | 602,093 | 626,133 | 682,138 | 719,398 | 10.98% | |
| - | ||||||||||||||
| Tax Rate | 11.72% | 16.26% | -87.81% | 5.66% | 19.59% | 27.55% | 16.58% | 22.62% | 20.55% | 14.34% | 15.47% | 13.69% | - | |
| Total Cost | 10,619,992 | 11,128,281 | 6,228,492 | 4,085,169 | 2,885,029 | 3,238,774 | 3,806,867 | 3,662,703 | 2,555,178 | 1,453,159 | 1,674,460 | 1,494,489 | 17.17% | |
| - | ||||||||||||||
| Net Worth | 11,570,586 | 11,570,586 | 10,807,049 | 9,909,248 | 9,174,381 | 8,545,994 | 8,052,542 | 7,575,172 | 7,410,748 | 6,841,930 | 6,199,111 | 5,425,948 | 7.95% | |
| Dividend | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Div | 590,524 | 438,003 | 1,330,917 | 306,471 | - | 150,811 | 296,412 | 296,097 | 291,570 | 289,095 | 282,849 | 275,895 | 19.09% | |
| Div Payout % | 69.24% | 49.14% | 72.40% | 38.01% | - | 40.58% | 41.98% | 57.62% | 48.43% | 46.17% | 41.47% | 38.35% | - | |
| Equity | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Worth | 11,570,586 | 11,570,586 | 10,807,049 | 9,909,248 | 9,174,381 | 8,545,994 | 8,052,542 | 7,575,172 | 7,410,748 | 6,841,930 | 6,199,111 | 5,425,948 | 7.95% | |
| NOSH | 2,769,642 | 2,769,642 | 2,662,493 | 2,553,930 | 2,513,528 | 2,513,527 | 2,472,322 | 2,467,991 | 2,429,753 | 2,409,130 | 2,357,076 | 2,299,130 | 1.64% | |
| Ratio Analysis | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NP Margin | 7.66% | 7.59% | 24.35% | 16.98% | 17.97% | 11.58% | 16.61% | 13.35% | 20.43% | 31.52% | 30.23% | 32.97% | - | |
| ROE | 7.37% | 7.70% | 17.01% | 8.14% | 6.41% | 4.35% | 8.77% | 6.78% | 8.12% | 9.15% | 11.00% | 13.26% | - | |
| Per Share | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RPS | 415.48 | 435.04 | 309.32 | 192.68 | 139.93 | 145.73 | 184.81 | 171.31 | 132.17 | 88.08 | 101.82 | 96.97 | 13.74% | |
| EPS | 31.27 | 32.20 | 69.93 | 31.96 | 23.41 | 14.94 | 28.60 | 20.89 | 24.78 | 25.99 | 28.94 | 31.29 | 9.34% | |
| DPS | 21.33 | 15.82 | 50.00 | 12.00 | 0.00 | 6.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 17.17% | |
| NAPS | 4.18 | 4.18 | 4.06 | 3.88 | 3.65 | 3.40 | 3.26 | 3.07 | 3.05 | 2.84 | 2.63 | 2.36 | 6.20% | |
| Adjusted Per Share Value based on latest NOSH - 2,769,642 | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RPS | 414.39 | 433.91 | 296.67 | 177.31 | 126.73 | 131.98 | 164.49 | 152.31 | 115.71 | 76.46 | 86.47 | 80.34 | 15.61% | |
| EPS | 30.73 | 32.12 | 66.24 | 29.05 | 21.20 | 13.39 | 25.44 | 18.52 | 21.69 | 22.56 | 24.58 | 25.92 | 10.98% | |
| DPS | 21.28 | 15.78 | 47.96 | 11.04 | 0.00 | 5.43 | 10.68 | 10.67 | 10.51 | 10.42 | 10.19 | 9.94 | 19.09% | |
| NAPS | 4.1691 | 4.1691 | 3.894 | 3.5705 | 3.3057 | 3.0793 | 2.9015 | 2.7295 | 2.6702 | 2.4653 | 2.2337 | 1.9551 | 7.95% | |
| Price Multiplier on Financial Quarter End Date | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | 30/04/24 | 30/04/24 | 31/07/23 | 29/07/22 | 30/07/21 | 30/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 29/07/16 | 31/07/15 | 31/07/14 | - | |
| Price | 5.31 | 5.31 | 4.30 | 3.75 | 2.80 | 3.56 | 3.71 | 3.87 | 5.30 | 4.82 | 4.82 | 4.78 | - | |
| P/RPS | 1.28 | 1.22 | 1.39 | 1.95 | 2.00 | 2.44 | 2.01 | 2.26 | 4.01 | 5.47 | 4.73 | 4.93 | -13.11% | |
| P/EPS | 17.23 | 16.49 | 6.23 | 11.88 | 11.96 | 24.07 | 12.98 | 18.58 | 21.39 | 18.55 | 16.66 | 15.28 | -9.48% | |
| EY | 5.80 | 6.06 | 16.06 | 8.42 | 8.36 | 4.15 | 7.71 | 5.38 | 4.68 | 5.39 | 6.00 | 6.55 | 10.47% | |
| DY | 4.02 | 2.98 | 11.63 | 3.20 | 0.00 | 1.69 | 3.23 | 3.10 | 2.26 | 2.49 | 2.49 | 2.51 | 18.56% | |
| P/NAPS | 1.27 | 1.27 | 1.06 | 0.97 | 0.77 | 1.05 | 1.14 | 1.26 | 1.74 | 1.70 | 1.83 | 2.03 | -6.96% | |
| Price Multiplier on Announcement Date | ||||||||||||||
| AQR | T4Q | 31/07/23 | 31/07/22 | 31/07/21 | 31/07/20 | 31/07/19 | 31/07/18 | 31/07/17 | 31/07/16 | 31/07/15 | 31/07/14 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | 25/06/24 | 25/06/24 | 27/09/23 | 29/09/22 | 29/09/21 | 25/09/20 | 27/09/19 | 28/09/18 | 28/09/17 | 28/09/16 | 28/09/15 | 29/09/14 | - | |
| Price | 6.50 | 6.50 | 4.31 | 3.85 | 3.02 | 3.25 | 3.56 | 3.36 | 5.29 | 4.90 | 4.50 | 4.81 | - | |
| P/RPS | 1.56 | 1.49 | 1.39 | 2.00 | 2.16 | 2.23 | 1.93 | 1.96 | 4.00 | 5.56 | 4.42 | 4.96 | -13.17% | |
| P/EPS | 21.10 | 20.18 | 6.24 | 12.20 | 12.90 | 21.98 | 12.45 | 16.13 | 21.35 | 18.85 | 15.55 | 15.37 | -9.52% | |
| EY | 4.74 | 4.95 | 16.02 | 8.20 | 7.75 | 4.55 | 8.03 | 6.20 | 4.68 | 5.30 | 6.43 | 6.51 | 10.51% | |
| DY | 3.28 | 2.43 | 11.60 | 3.12 | 0.00 | 1.85 | 3.37 | 3.57 | 2.27 | 2.45 | 2.67 | 2.49 | 18.63% | |
| P/NAPS | 1.56 | 1.56 | 1.06 | 0.99 | 0.83 | 0.96 | 1.09 | 1.09 | 1.73 | 1.73 | 1.71 | 2.04 | -7.01% | |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
6 people like this. Showing 50 of 17,341 comments
Major US stock indices is in the red. Interesting to see how Gamuda share price gonna perform ..
5 days ago
All the US major indices are showing down ...tomorrow is a good day to grab while Gamuda is making corrections
5 days ago
Gamuda Bhd is expected to secure another data centre (DC) project in the financial year 2025 (FY25), according to RHB Research.
https://www.nst.com.my/business/corporate/2024/07/1077194/gamuda-bag-another-big-dc-job#google_vignette
5 days ago
Another 10% stock market correction is likely in the next two weeks. World market will drop 10-20% too...better sell now & run...
5 days ago
paktua late came..
just manage grab rm7.95 right now
for 43 stage
huhu
tut tut
if more lower paktua will reload more
5 days ago
When analyst upgrades the TP to sky high, the legend is end..
Please revisit TOP glove, SUPERMX history
4 days ago
It depends on how long you wanna hold this share. ? Whether you believe in the growth story ? For me, Gamuda is very capable to win overseas contract especially in Singapore when performance matters and competition is intense ..not like in Malaysia wher you get just a few big fish swimming in a small pond
4 days ago
Gamuda is a good stock to buy, keep, and grow it! I managed to grab SOME at 7.92 today
4 days ago
Need to push price gains more than +0.250 to make sure counter returns back to normal. Otherwise intraday traders who bought cheap yesterday will try to goreng to make fast profit by noon.
4 days ago
yes now gamida back at rm8.11
hopefully will reach back rm8.40 by aug
tut tut
let ride
4 days ago
I got positions in both Gamuda + IJM.
Looking to load up on Gadang...as it is the only small / medium cap company with exposure to data center.
TA is right on one thing that Gadang has close working relationship with TM all these years .
4 days ago
Sometimes, volume matters as well...buy Gadang on the cheap, you gain on low base + high volume.
4 days ago
We need jokers like Biden + Trump to talk through their ass...we also need jokers to sell down on big tech and semicon counters in the US ...send some jitters in the market...allow us to hive off those high entry price and buy back on the low... Correct the portfolio and increase the margin of safety.
4 days ago
TSMC quarterly results beat expectation and revise their next year revenue forecast higher. We are on the edge for a semi con super cycle....and yet we got jokers telling us semi con cycle is coming to an end. ..don't trust me...come to Penang...get off the second link ...travel to Batu Kawan and Bayan Lepas industrial park...look at how Lam Research, Intel, AmD , Micron expanding in Penang....look at the cranes anf how IJM benefit from building these industrial building projects
4 days ago
Last Thursday, Gamuda announced the securing of an AUD 1.6 billion (MYR 5 billion) contract, causing its share price to soar to a historic high. Although the stock price experienced a slight dip on last Friday, it has still risen by more than 80% since the beginning of the year.
4 days ago
9:50 pm 24.7.24
NASDAQ Composite (^IXIC)
17,675.16
-322.19
(-1.79%)
S&P 500 (^GSPC)
5,497.87
-57.87
(-1.04%)
Dow Jones Industrial Average (^DJI)
40,215.51
-142.58
(-0.35%)
2 days ago
morning..
yes manage grap more at rm7.84ntill rm7.85
tut tut
will eat more for final stage if break rm7.60
2 days ago
Fundamentals intact. Market sentiment disturbed by temporary correction in US market. Will bull again to new heights after correction
2 days ago
Gamuda, IJM, Suncon the 3 kings of construction all got very strong fundamentals. Only slight retracement recently due to US correction which is a temporary healthy correction before the next wave of bull run..
23 hours ago
So frequently issuing ESOS. 92,200 shares. Timing of issuance during US Market fall. Huge retracement. Now it takes time to climb back up again.
18 hours ago
Need to pump price higher before Dividend Ex date. Going to have 0.100 price adjustment after Ex date. Not including other sell off that may occur due to any upcoming market sentiment.
17 hours ago
Depends on what you do with the dividend. Gamuda offers dividend reinvestment plan - so, can convert dividend to shares . Free shares lower the cost of investment.
1 hour ago
Investing in Gamuda can bring both capital appreciation and dividend income 🤗
17 minutes ago
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-07-26 16:10:00
EMA 5
5 Mins
SELL
2024-07-26 16:00:00
EMA 5
10 Mins
SELL
2024-07-26 15:55:00
EMA 5
5 Mins
BUY
2024-07-26 15:50:00
EMA 5
10 Mins
BUY
2024-07-26 15:25:00
EMA 5
5 Mins
SELL
Apps
Top Articles
1
save malaysia!
2
MQ Market Updates
3
BFM Podcast
4
BFM Podcast
5
M+ Online Research Articles
6
BFM Podcast
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Riaz1954
I concur with sentiments made by members in this forum on MHRA will be the first to approve TauRX. Don’t forget TaURX is based in Aberdeen and naturally has some relationship with the authorities in the UK. Also TaURX with its low implementation costs suits cash strapped NHS. Under the new fast track approval process the timeline suggests we could see action during 4th qtr! Fingers crossed. Genting insiders is my big concern as in the past have proven to be untrustworthy, perhaps they may changed the spots!
5 days ago